| Literature DB >> 34814929 |
Yong Huang1, Jiayuan Hao1, Yuan Liao1, Lihua Zhou1, Kaiju Wang1, Hui Zou1, Ying Hu1, Juan Li2.
Abstract
BACKGROUND: Recurrent spontaneous abortion (RSA) is one of the common complication of pregnancy, bringing heavy burden to the patients and their families. The study aimed to explore the lncRNA-miRNA-mRNA network associated with recurrent spontaneous abortion.Entities:
Keywords: Recurrent spontaneous abortion; Transcriptome sequencing; ceRNA network; lncRNA
Mesh:
Substances:
Year: 2021 PMID: 34814929 PMCID: PMC8609870 DOI: 10.1186/s12920-021-01125-4
Source DB: PubMed Journal: BMC Med Genomics ISSN: 1755-8794 Impact factor: 3.063
Fig. 1Heatmap analysis of DEL, DEM and DEGs. DEL: Differentially expressed lncRNAs; DEMs: Differentially expressed miRNAs; DEGs: Differentially expressed genes
Top 20 downregulated DELsand DEGs
| Name | Log2FC | FDR | |
|---|---|---|---|
| lnc-LUC7L-2 | − 12.39733625 | 2.73E−23 | 4.473E−19 |
| lnc-SVIL-1 | − 10.14199781 | 0.009439 | 0.8407162 |
| lnc-GYPB-2 | − 10.04160545 | 1.05E−14 | 6.891E−11 |
| lnc-TAL1-3 | − 9.098739111 | 1.69E−11 | 6.145E−08 |
| lnc-GPAT4-4 | − 8.301384128 | 2.41E−09 | 7.187E−06 |
| lnc-CXorf58-2 | − 8.001569916 | 0.040642 | 0.9999888 |
| lnc-TAL1-2 | − 7.993599712 | 1.46E−07 | 0.0003185 |
| lnc-TAL1-1 | − 7.473540526 | 5.28E−07 | 0.0010197 |
| lnc-CCDC80-5 | − 7.360578289 | 1.01E−14 | 6.891E−11 |
| lnc-GPX2-4 | − 7.17832599 | 2.87E−06 | 0.0047 |
| lnc-GCDH-3 | − 7.146089066 | 4.05E−06 | 0.0055418 |
| lnc-ZNF674-14 | − 6.715903208 | 5.78E−05 | 0.0364908 |
| lnc-ANKRD34B-1 | − 6.594566822 | 0.000117 | 0.065244 |
| lnc-SLC4A1-1 | − 6.591100728 | 3.72E−05 | 0.0259794 |
| IL21R-AS1 | − 6.574007081 | 0.000154 | 0.0803045 |
| lnc-NT5C2-1 | − 6.499432393 | 0.000265 | 0.1146595 |
| lnc-LRRC71-4 | − 6.493785307 | 0.001977 | 0.4445064 |
| lnc-EEF1A1-1 | − 6.4933232 | 0.000141 | 0.074564 |
| lnc-MTA3-2 | − 6.457648098 | 0.000217 | 0.098679 |
| lnc-TBC1D2B-8 | − 6.446282105 | 0.000182 | 0.0916568 |
| HBZ | − 12.29877063 | 1.1E−17 | 2.346E−14 |
| HBE1 | − 12.08390031 | 1.16E−08 | 6.391E−06 |
| CTSE | − 10.90211575 | 2.04E−17 | 3.882E−14 |
| PKLR | − 10.5396262 | 6.11E−15 | 6.549E−12 |
| HBG1 | − 10.25889722 | 9.69E−10 | 6.64E−07 |
| AHSP | − 10.18762318 | 2.16E−15 | 2.614E−12 |
| GYPB | − 9.839459815 | 6.36E−14 | 6.411E−11 |
| RHAG | − 9.68168386 | 6.79E−13 | 6.123E−10 |
| HBG2 | − 9.436337355 | 6.3E−129 | 1.07E−124 |
| TGIF2-RAB5IF | − 9.153251114 | 0.019158 | 0.674672 |
| CD5L | − 8.968198622 | 4.78E−09 | 2.826E−06 |
| GFI1B | − 8.740214677 | 1.55E−09 | 9.851E−07 |
| KLF1 | − 8.631727943 | 4.25E−10 | 3.164E−07 |
| ABHD14A-ACY1 | − 8.592860821 | 0.027891 | 0.7822296 |
| TRIM10 | − 8.290726755 | 4.07E−09 | 2.49E−06 |
| SLC4A1 | − 7.487911126 | 1.84E−73 | 1.575E−69 |
| DUS4L-BCAP29 | − 7.463007241 | 1.78E−15 | 2.352E−12 |
| FAM83A | − 7.25200236 | 0.002489 | 0.2557698 |
| GYPA | − 7.056613955 | 6.81E−14 | 6.484E−11 |
| APOC3 | − 6.933554968 | 0.00925 | 0.4944919 |
Log2FoldChange: Log2FC; DEL: differential expression LncRNAs; DEGs: differential expression genes
Top 15 upregulated DEMs
| Name | Log2FC | FDR | |
|---|---|---|---|
| hsa-let-7d-3p | 2.3366134 | 0.0022868 | 0.1875138 |
| chr19_19396 | 2.327217 | 0.0003966 | 0.4314759 |
| hsa-miR-6715b-3p | 2.2766042 | 0.0036217 | 0.2375866 |
| hsa-miR-10b-5p | 1.7264499 | 0.0004681 | 0.0658066 |
| hsa-miR-210-5p | 1.711749 | 0.0080521 | 0.4170136 |
| hsa-miR-181c-5p | 1.6300442 | 0.0079254 | 0.4170136 |
| hsa-let-7b-5p | 1.6297179 | 0.0015161 | 0.1421603 |
| hsa-let-7i-5p | 1.6187541 | 0.0008794 | 0.0979275 |
| hsa-miR-187-3p | 1.5738613 | 0.0015892 | 0.1421603 |
| hsa-miR-653-5p | 1.432427 | 0.0097668 | 0.4452522 |
| hsa-let-7d-5p | 1.3072349 | 0.0325617 | 0.9977985 |
| hsa-miR-874-3p | 1.2936117 | 0.0135001 | 0.5535043 |
| hsa-miR-10b-3p | 1.2624656 | 0.0379635 | 0.9977985 |
| hsa-miR-146a-5p | 1.1734703 | 0.0460092 | 0.9977985 |
| hsa-miR-3690 | 1.1308818 | 0.045213 | 0.9977985 |
Log2FoldChange: Log2FC; DEMs: differential expression miRNAs
Top 10 enriched GO pathways of DELs
| Terms | Pathway description | Count | |
|---|---|---|---|
| GO:0050878 | Regulation of body fluid levels | 25 | 0.000139 |
| GO:0048706 | Embryonic skeletal system development | 12 | 2.5E−05 |
| GO:0099173 | Postsynapse organization | 11 | 0.000945 |
| GO:1901264 | Carbohydrate derivative transport | 7 | 0.000968 |
| GO:0007257 | Activation of JUN kinase activity | 6 | 0.000215 |
| GO:0033598 | Mammary gland epithelial cell proliferation | 5 | 0.000357 |
| GO:0015671 | Oxygen transport | 4 | 0.00028 |
| GO:0015669 | Gas transport | 4 | 0.000741 |
| GO:0033599 | Regulation of mammary gland epithelial cell proliferation | 4 | 0.000596 |
| GO:0060039 | Pericardium development | 4 | 0.000911 |
| GO:0005667 | Transcription factor complex | 17 | 0.002842 |
| GO:0033267 | Axon part | 17 | 0.004541 |
| GO:0099572 | Postsynaptic specialization | 16 | 0.004294 |
| GO:0035097 | Histone methyltransferase complex | 7 | 0.003545 |
| GO:0005905 | Clathrin-coated pit | 6 | 0.003517 |
| GO:0044665 | MLL1/2 complex | 4 | 0.003743 |
| GO:0005833 | Hemoglobin complex | 4 | 0.000105 |
| GO:0071339 | MLL1 complex | 4 | 0.003743 |
| GO:0031838 | Haptoglobin-hemoglobin complex | 4 | 7.15E−05 |
| GO:0000145 | Exocyst | 4 | 0.000728 |
| GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific | 22 | 0.001229 |
| GO:0001158 | Enhancer sequence-specific DNA binding | 11 | 0.000132 |
| GO:0035326 | Enhancer binding | 11 | 0.000351 |
| GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 11 | 2.65E−05 |
| GO:0016651 | Oxidoreductase activity, acting on NAD(P)H | 8 | 0.004119 |
| GO:0140104 | Molecular carrier activity | 5 | 0.003458 |
| GO:0019894 | Kinesin binding | 5 | 0.002799 |
| GO:0043236 | Laminin binding | 4 | 0.004743 |
| GO:0031720 | Haptoglobin binding | 4 | 6E−05 |
| GO:0005344 | Oxygen carrier activity | 4 | 0.000265 |
BP: Biological process; CC: cellular component; MF: molecular function
Fig. 2GO enrichment items and KEGG pathway analysis of DELs. a Showed that the top 10 enriched GO pathways of DELs were sorted by significance in biological process (BP), cellular component (CC) and molecular function (MF), respectively. b Showed the top 10 enriched KEGG pathways of DELs
Top 10 enriched KEGG pathways of DELs
| ID | Pathway description | Count | |
|---|---|---|---|
| hsa05010 | Alzheimer disease | 14 | 0.025553 |
| hsa04714 | Thermogenesis | 11 | 0.010243 |
| hsa04919 | Thyroid hormone signaling pathway | 9 | 0.0010683 |
| hsa04390 | Hippo signaling pathway | 9 | 0.0062426 |
| hsa05225 | Hepatocellular carcinoma | 8 | 0.0268635 |
| hsa04520 | Adherens junction | 5 | 0.0173581 |
| hsa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 5 | 0.0238119 |
| hsa05110 | Vibrio cholerae infection | 4 | 0.0213693 |
| hsa00601 | Glycosphingolipid biosynthesis—lacto and neolacto series | 3 | 0.0190689 |
| hsa01523 | Antifolate resistance | 3 | 0.0275527 |
Top 10 enriched GO terms of DEGs
| Terms | Pathway description | Count | |
|---|---|---|---|
| GO:0010959 | Regulation of metal ion transport | 23 | 1.5E−05 |
| GO:0007159 | Leukocyte cell–cell adhesion | 22 | 5.16E−06 |
| GO:0070663 | Regulation of leukocyte proliferation | 17 | 8.10E−06 |
| GO:0019882 | Antigen processing and presentation | 15 | 9.95E−06 |
| GO:0017001 | Antibiotic catabolic process | 9 | 4.59E−06 |
| GO:0015669 | Gas transport | 9 | 1E−10 |
| GO:0045123 | Cellular extravasation | 9 | 2.88E−06 |
| GO:0042744 | Hydrogen peroxide catabolic process | 8 | 3.94E−07 |
| GO:0015671 | Oxygen transport | 7 | 1.5E−08 |
| GO:0072677 | Eosinophil migration | 6 | 1.52E−05 |
| GO:0031012 | Extracellular matrix | 27 | 1.57E−05 |
| GO:0015629 | Actin cytoskeleton | 24 | 0.000225 |
| GO:0043292 | Contractile fiber | 15 | 0.000198 |
| GO:0044449 | Contractile fiber part | 15 | 9.38E−05 |
| GO:0030016 | Myofibril | 14 | 0.000392 |
| GO:0030017 | Sarcomere | 14 | 0.000138 |
| GO:0005833 | Hemoglobin complex | 8 | 1.1E−08 |
| GO:0031838 | Haptoglobin-hemoglobin complex | 7 | 7.81E−10 |
| GO:0042611 | MHC protein complex | 5 | 0.000195 |
| GO:0042613 | MHC class II protein complex | 4 | 0.000354 |
| GO:0003779 | Actin binding | 22 | 0.000437 |
| GO:0051015 | Actin filament binding | 14 | 0.000169 |
| GO:0043177 | Organic acid binding | 14 | 0.000351 |
| GO:0140104 | Molecular carrier activity | 9 | 5.64E−07 |
| GO:0016209 | antioxidant activity | 9 | 0.000189 |
| GO:0019825 | Oxygen binding | 8 | 1.49E−06 |
| GO:0004601 | Peroxidase activity | 8 | 2.67E−05 |
| GO:0016684 | Oxidoreductase activity, acting on peroxide as acceptor | 8 | 4.65E−05 |
| GO:0031720 | Haptoglobin binding | 7 | 4.3E−10 |
| GO:0005344 | Oxygen carrier activity | 7 | 1.13E−08 |
BP: Biological process; CC: cellular component; MF: molecular function
Fig. 3GO enrichment items and KEGG pathway analysis of DEGs. a Showed that the top 10 enriched GO pathways of DEGs were sorted by significance in biological process (BP), cellular component (CC) and molecular function (MF), respectively. b Showed the top 10 enriched KEGG pathways of DEGs
Top 10 enriched KEGG pathways of DEGs
| ID | Pathway description | Count | |
|---|---|---|---|
| hsa04514 | Cell adhesion molecules (CAMs) | 12 | 0.00023 |
| hsa04062 | Chemokine signaling pathway | 12 | 0.00204 |
| hsa05150 | Staphylococcus aureus infection | 10 | 1E−04 |
| hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 10 | 0.00014 |
| hsa05144 | Malaria | 8 | 2.3E−05 |
| hsa04662 | B cell receptor signaling pathway | 8 | 0.00078 |
| hsa05140 | Leishmaniasis | 7 | 0.00248 |
| hsa05310 | Asthma | 6 | 8.2E−05 |
| hsa05143 | African trypanosomiasis | 5 | 0.00182 |
| hsa05330 | Allograft rejection | 5 | 0.00205 |
Fig. 4The interactions between lncRNA-miRNA and miRNA-genes were determined, respectively. a Showed the relationship between downregulated lncRNAs and upregulated miRNAs. b Listed the interactions between hsa-miR-210-5p and 3 genes
Fig. 5The ceRNA network was constructed between DELs, DEMs and DEGs
Construction of ceRNA network (Top 20)
| lncRNA | lncRNA_miRNA cor | miRNA | miRNA_mRNA cor | mRNA | mRNA_lncRNA cor | |||
|---|---|---|---|---|---|---|---|---|
| PSD2-AS1 | -12.39733625 | 0.01666667 | hsa-miR-210-5p | − 0.9428571 | 0.01666667 | GRIA1 | 0.8857143 | 0.03333333 |
| PSD2-AS1 | -10.14199781 | 0.01666667 | hsa-miR-210-5p | − 0.8857143 | 0.03333333 | AQP1 | 0.9428571 | 0.01666667 |
| PSD2-AS1 | -10.04160545 | 0.01666667 | hsa-miR-210-5p | − 0.8804063 | 0.02059873 | NTNG2 | 0.9411239 | 0.005097541 |
| lnc-ACAN-2 | -9.098739111 | 0.03410942 | hsa-miR-210-5p | − 0.9428571 | 0.01666667 | GRIA1 | 0.8451543 | 0.03410942 |
| lnc-ACAN-2 | -8.301384128 | 0.03410942 | hsa-miR-210-5p | − 0.8857143 | 0.03333333 | AQP1 | 0.7775419 | 0.06872694 |
| lnc-ACAN-2 | -8.001569916 | 0.03410942 | hsa-miR-210-5p | − 0.8804063 | 0.02059873 | NTNG2 | 0.8261844 | 0.04269215 |
| lnc-STON1-1 | -7.993599712 | 0.03333333 | hsa-miR-210-5p | − 0.9428571 | 0.01666667 | GRIA1 | 0.7714286 | 0.1027778 |
| lnc-STON1-1 | -7.473540526 | 0.03333333 | hsa-miR-210-5p | − 0.8857143 | 0.03333333 | AQP1 | 1 | 0.002777778 |
| lnc-STON1-1 | -7.360578289 | 0.03333333 | hsa-miR-210-5p | − 0.8804063 | 0.02059873 | NTNG2 | 0.9411239 | 0.005097541 |
| lnc-HPS4-8 | -7.17832599 | 0.02059873 | hsa-miR-210-5p | − 0.9428571 | 0.01666667 | GRIA1 | 0.8804063 | 0.02059873 |
cor: Correlation
p value < 0.05 and cor ≤ −0.8 indicate that there is a negative correlation